[Norwegian drug policy--socioeconomically unprofitable, hostile to patients and to research].
Jacobsen
T K
TK
NO-RE-FARM, Oslo.
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D009664:Norway; D010361:Patients; D012106:Research; D012959:Socioeconomic Factors
Norsk legemiddelpolitikk--samfunnsøkonomisk ulønnsom, pasient--og forskningsfiendtlig.